Optic Nerve Preservation with coMra Therapy

Preserve Sight at the Source — Non-Invasive, Adjunctive, Safe

coMra therapy is a clinically-backed, in-office solution to support optic nerve health in glaucoma, diabetic retinopathy, stroke recovery, and more.

👉 View the Eye Protocol

🔍 See Clinical Case Gallery

Evidence at a glance: Case: optic neuritis improved after 18 sessions • Study: Egorov (POAG, 165 eyes) showed visual-field gains vs control. Details


Vision Lost Is Often Irreversible — But Not Always Unavoidable

In conditions like glaucoma, ischemic neuropathy, or post-stroke field loss, patients often arrive already in decline.

Once vision is lost, conventional tools can only stabilize what’s left.

But what if you could intervene earlier — or support regeneration, not just protection?

“By the time symptoms appear, over 40% of optic nerve fibers may already be lost.”* — American Academy of Ophthalmology


A Regenerative Modality That Fits Your Workflow

coMra is a non-invasive, low-intensity in-office adjunct that supports optic-nerve metabolism, visual comfort, and field resilience —used alongside standard care

  • 10–20 minute, staff-delivered sessions over closed eyelids; integrates with existing visits
  • Non-pharmacologic, non-thermal, no observed adverse effects
  • Suitable across early, advanced, and complex cases as supportive care
  • Early patient shifts often include easier visual comfort and a calmer overall state

📥 Read the Clinical Brief · See Clinical Case Gallery · View the Eye Protocol

📖 How coMra Therapy Works →

What it is / is not

IsIs not
Non-thermal adjunct delivered over closed eyelidsSurgery or laser ablation
Staff-delivered, 10–20 minute sessionsHeat therapy
Used alongside standard careA replacement for standard of care

What Doctors Are Seeing in Practice

Case Highlights:

Each case followed the same foundation: Delta 905 device + Eye Protocol + course of treatment

📥 Read the Clinical Brief

Across featured cases: fusion restored (post-stroke); VI nerve function restored (post-op); visual field >2.5× expansion (PDR/ischemia).


You Don’t Have to Change Everything

coMra therapy is designed to support what you already do.

It doesn’t replace your primary care tools — it enhances them.

  • Use it adjunctively with IOP medications
  • Support recovery after surgery or trauma
  • Bridge gaps where conventional tools plateau

All it takes is:

  • A Delta 905 device
  • Our ready-made Eye Protocol
  • 10-20 minutes per session

Your clinical staff can learn it in a single afternoon.

First 30 days (suggested)

  • Week 1: Train one tech; set up Delta 905; review Eye Protocol
  • Week 2: Start 3 pilot patients (glaucoma/ischemia, post-stroke, neuritis)
  • Week 3: Log comfort/VA/contrast notes; schedule fields where appropriate
  • Week 4: Review outcomes; decide on next 5 candidates; refine flow

Next steps: View the Eye Protocol · Book a Quick Call · 📨 Ask a Clinical Question


Evidence details: Optic Neuritis Case →Egorov (2013) Digest →


Built on Decades of Research and Clinical Observation

Delivered together because these pathways co-regulate recovery — energy ⇄ transport ⇄ rhythm.

coMra delivers IR laser, magnetic field, ultrasound, and sequenced colour light simultaneously to support three recovery fundamentals:

  • Cellular energy: photomagnetic support for mitochondrial function and neuroprotective signalling
  • Molecular transport: ultrasound-assisted microcirculation and diffusion
  • Regulatory rhythm: sequenced colour pacing to help re-sync autonomic/immune rhythms

Delivered together—not in isolation—this mechanism set corresponds to observed visual-field stability and neuro-ocular resilience in practice.

Scientific References: The studies below help illuminate the mechanisms and benefits behind coMra therapy’s effects in eye health and neuro-regeneration:

  • Egorov (2013) — Transcranial magneto-laser in POAG (n=165 eyes)
  • Novikova (2011) — Bio-regulated ultrasound in glaucoma (n=157 treated; 49 control eyes)
  • Baranov (2016) — Chronophysiotherapy across optic-nerve disorders (n=443 eyes; durable gains)

▶️ These are representative examples — see more in the 📖 Research Digest

Quick links: FAQ: Safety · Clinical Case Gallery · See the Clinical Brief · Book a Quick Call


Who this is ideal for

  • Neuro-optometry & rehab: post-stroke fields, cranial nerve palsy, fusion issues
  • Medical ODs (glaucoma/ischemia): field preservation when IOP control isn’t enough
  • Vision therapy / syntonics-friendly clinics: adjunct for neural function support

Your Patients Are Already Losing Vision. Now You Have Options.

Whether you’re exploring alternatives…
…looking for something to add…
…or already know your patients need more support —
this is a starting point.

coMra therapy isn’t a replacement for the tools you trust.
It’s a new way to help preserve what matters most.

  • Start with a single case
  • Use it alongside your current protocols
  • Let your staff deliver the sessions
  • Or empower patients directly with home-use options home-use

For Your Team. For Your Patients. For What Comes Next.

Once you see the benefits of coMra in your clinic, your technicians, patients, and colleagues will want to know more.

We’re preparing accessible, plug-and-play resources to help you extend care with confidence:

  • Quick-start guides for technician onboarding
  • Patient education tools and take-home materials
  • In-practice treatment flow charts
  • Staff Briefing materials
  • Patient Briefing materials
  • Quick Reference Card for Clinic Staff
  • Home use guides

📥 Get Early Access to Staff & Patient Resources


Let’s Protect What Matters Most — While We Still Can

You already work to preserve sight.
Let us help you extend what’s possible — starting at the source.

We’ll support you with clinical guides, case data, and live onboarding.

View the Eye Protocol 🔍 See Clinical Case Gallery 📞 Talk to Our Team